FDA advisers back Pfizer-BioNTech coronavirus vaccine for ages 5 to 11, saying benefits outweigh risks - The Washington Post
WWW.WASHINGTONPOST.COM
The Food and Drug Administration is all but certain to authorize the vaccine in coming days, meaning it could become available in early November.